Cargando…
Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794468/ https://www.ncbi.nlm.nih.gov/pubmed/31649526 http://dx.doi.org/10.3389/fnagi.2019.00273 |
_version_ | 1783459300958535680 |
---|---|
author | Haytural, Hazal Lundgren, Jolanta L. Köse, Tansu B. Jordà-Siquier, Tomàs Kalcheva, Marinela Seed Ahmed, Mohammed Winblad, Bengt Sundström, Erik Barthet, Gaël Tjernberg, Lars O. Frykman, Susanne |
author_facet | Haytural, Hazal Lundgren, Jolanta L. Köse, Tansu B. Jordà-Siquier, Tomàs Kalcheva, Marinela Seed Ahmed, Mohammed Winblad, Bengt Sundström, Erik Barthet, Gaël Tjernberg, Lars O. Frykman, Susanne |
author_sort | Haytural, Hazal |
collection | PubMed |
description | The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ)-peptide, its amyloid precursor protein (APP) and the intermediate APP-c-terminal fragments (APP-CTFs) are all important players in AD pathogenesis. In order to elucidate which APP CTF that are the most common in brain tissue of different species and developmental stages, and whether there are any differences in these fragments between AD and control brain, we investigated the occurrence of these fragments using different APP c-terminal antibodies. We noticed that whereas the conventional APP-CTFα and CTFβ fragments were most prominent in rat and mouse brain tissue, the major western blotting band detected in human, macaque and guinea pig was of approximately 20 kDa in size, possibly corresponding to the newly discovered APP-CTFη. However, this band was also intensely stained with a total protein stain, as well as by several other antibodies. The staining intensity of the 20 kDa band by the APP antibodies varied considerably between samples and correlated with the staining intensity of this band by the total protein stain. This could potentially be due to non-specific binding of the antibodies to another protein of this size. In-gel digestion and mass spectrometry confirmed that small amounts of APP were present in this band, but many other proteins were identified as well. The major hit of the mass spectrometry analysis was myelin basic protein (MBP) and a myelin removal protocol removed proportionally more of the 20 kDa APP band than the full-length APP and APP-CTFα/β bands. However, the signal could not be immunodepleted with an MBP antibody. In summary, we report on a potentially non-specific western blotting band of approximately 20 kDa and call for precaution when analyzing proteins of this size in human brain tissue. |
format | Online Article Text |
id | pubmed-6794468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67944682019-10-24 Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies Haytural, Hazal Lundgren, Jolanta L. Köse, Tansu B. Jordà-Siquier, Tomàs Kalcheva, Marinela Seed Ahmed, Mohammed Winblad, Bengt Sundström, Erik Barthet, Gaël Tjernberg, Lars O. Frykman, Susanne Front Aging Neurosci Neuroscience The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ)-peptide, its amyloid precursor protein (APP) and the intermediate APP-c-terminal fragments (APP-CTFs) are all important players in AD pathogenesis. In order to elucidate which APP CTF that are the most common in brain tissue of different species and developmental stages, and whether there are any differences in these fragments between AD and control brain, we investigated the occurrence of these fragments using different APP c-terminal antibodies. We noticed that whereas the conventional APP-CTFα and CTFβ fragments were most prominent in rat and mouse brain tissue, the major western blotting band detected in human, macaque and guinea pig was of approximately 20 kDa in size, possibly corresponding to the newly discovered APP-CTFη. However, this band was also intensely stained with a total protein stain, as well as by several other antibodies. The staining intensity of the 20 kDa band by the APP antibodies varied considerably between samples and correlated with the staining intensity of this band by the total protein stain. This could potentially be due to non-specific binding of the antibodies to another protein of this size. In-gel digestion and mass spectrometry confirmed that small amounts of APP were present in this band, but many other proteins were identified as well. The major hit of the mass spectrometry analysis was myelin basic protein (MBP) and a myelin removal protocol removed proportionally more of the 20 kDa APP band than the full-length APP and APP-CTFα/β bands. However, the signal could not be immunodepleted with an MBP antibody. In summary, we report on a potentially non-specific western blotting band of approximately 20 kDa and call for precaution when analyzing proteins of this size in human brain tissue. Frontiers Media S.A. 2019-10-09 /pmc/articles/PMC6794468/ /pubmed/31649526 http://dx.doi.org/10.3389/fnagi.2019.00273 Text en Copyright © 2019 Haytural, Lundgren, Köse, Jordà-Siquier, Kalcheva, Seed Ahmed, Winblad, Sundström, Barthet, Tjernberg and Frykman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Haytural, Hazal Lundgren, Jolanta L. Köse, Tansu B. Jordà-Siquier, Tomàs Kalcheva, Marinela Seed Ahmed, Mohammed Winblad, Bengt Sundström, Erik Barthet, Gaël Tjernberg, Lars O. Frykman, Susanne Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title | Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title_full | Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title_fullStr | Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title_full_unstemmed | Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title_short | Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies |
title_sort | non-specific detection of a major western blotting band in human brain homogenates by a multitude of amyloid precursor protein antibodies |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794468/ https://www.ncbi.nlm.nih.gov/pubmed/31649526 http://dx.doi.org/10.3389/fnagi.2019.00273 |
work_keys_str_mv | AT hayturalhazal nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT lundgrenjolantal nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT kosetansub nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT jordasiquiertomas nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT kalchevamarinela nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT seedahmedmohammed nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT winbladbengt nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT sundstromerik nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT barthetgael nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT tjernberglarso nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies AT frykmansusanne nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies |